Wedbush Securities Inc Lexicon Pharmaceuticals, Inc. Transaction History

Wedbush Securities Inc

$2.7 Billion
Q3 2024

A detailed history of Wedbush Securities Inc transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Wedbush Securities Inc holds 40,850 shares of LXRX stock, worth $31,454. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,850

Previous 40,850 -0.0%

Holding current value

$31,454

Previous $69,000 7.25%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$1.54 - $2.28 $1,232 - $1,823	-800 Reduced 1.92%	40,850 $69,000
Q1 2024 May 14, 2024	BUY	$1.3 - $3.58 $54,145 - $149,107	41,650 New	41,650 $100,000
Q4 2020 Feb 16, 2021	SELL	$1.05 - $3.67 $336,534 - $1.18 Million	-320,509 Closed	0 $0
Q3 2020 Oct 20, 2020	SELL	$1.44 - $2.1 $95,797 - $139,704	-66,526 Reduced 17.19%	320,509 $462,000
Q2 2020 Jul 16, 2020	BUY	$1.75 - $2.3 $57,312 - $75,325	32,750 Added 9.24%	387,035 $772,000
Q1 2020 Apr 17, 2020	SELL	$1.8 - $4.28 $24,078 - $57,253	-13,377 Reduced 3.64%	354,285 $691,000
Q4 2019 Jan 16, 2020	SELL	$3.16 - $5.15 $98,029 - $159,763	-31,022 Reduced 7.78%	367,662 $1.53 Million
Q3 2019 Oct 17, 2019	BUY	$1.2 - $6.66 $245,214 - $1.36 Million	204,345 Added 105.15%	398,684 $1.2 Million
Q2 2019 Aug 01, 2019	BUY	$5.35 - $7.11 $257,773 - $342,574	48,182 Added 32.97%	194,339 $1.22 Million
Q1 2019 Apr 17, 2019	SELL	$4.36 - $7.94 $123,322 - $224,582	-28,285 Reduced 16.21%	146,157 $813,000
Q4 2018 Jan 31, 2019	BUY	$6.15 - $10.51 $303,268 - $518,269	49,312 Added 39.41%	174,442 $1.16 Million
Q3 2018 Nov 13, 2018	SELL	$10.32 - $13.06 $270,590 - $342,433	-26,220 Reduced 17.32%	125,130 $1.34 Million
Q2 2018 Aug 03, 2018	SELL	$7.8 - $13.69 $31,558 - $55,389	-4,046 Reduced 2.6%	151,350 $1.82 Million
Q1 2018 May 01, 2018	BUY	$7.86 - $11.39 $128,039 - $185,543	16,290 Added 11.71%	155,396 $1.33 Million
Q4 2017 Feb 09, 2018	BUY	$8.77 - $12.28 $235,676 - $330,000	26,873 Added 23.94%	139,106 $1.37 Million
Q3 2017 Oct 31, 2017	BUY	$12.17 - $16.3 $1.37 Million - $1.83 Million	112,233	112,233 $1.38 Million

Others Institutions Holding LXRX

# of Institutions

141

Shares Held

238M

Call Options Held

459K

Put Options Held

133K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $145M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.

Account

Wedbush Securities Inc Lexicon Pharmaceuticals, Inc. Transaction History